Seeking Alpha

Isis Pharmaceuticals (ISIS) +15% today after an upgrade to Outperform on valuation at Cowen. The...

Isis Pharmaceuticals (ISIS) +15% today after an upgrade to Outperform on valuation at Cowen. The firm cites optimism surrounding its antisense platform and a strong pipeline that includes its cholesterol treatment Kynamro, which should get FDA approval early next year.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)